Influence of remnant accumulation markers on plasma concentrations of two lipoprotein(a) subspecies (containing or free of apoE)

Metabolism: Clinical and Experimental

Volumn 50, Issue 3, 2001, Pages 277-282

  Bach Ngohou, K ^a,b,c   Giraud, F ^a,b,c   Krempf, M ^a,b,c   Bard, J M ^a,b,c  

^a HÔTEL DIEU   (France)

^b Clinique d'Endocrinologie Hotel Dieu CHU de Nantes   (France)

^c Institut pour la Santé de l'Ouest   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BIOCHEMICAL MARKER; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; ATHEROSCLEROSIS; BINDING KINETICS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE MARKER; FUNCTIONAL ASSESSMENT; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MULTIPLE REGRESSION; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPECIES DIFFERENCE; STRUCTURE ANALYSIS;

EID: 0035079139     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.21031     Document Type: Article

References (33)

1. Lp (a) glycoprotein phenotypes, inheritance and relation to Lp (a)-lipoprotein concentrations in plasma
2. Lipoprotein (a) concentration in various hyperlipidemias
3. Lp (a) lipoprotein: Relationship to cardiovascular disease risk factors, exercise, and estrogen
4. Plasma concentration of lipoprotein (a) and the risk of future stroke
5. Lipoprotein Lp (a) as a predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: Results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)
6. Coronary artery disease is associated with increased lipoprotein (a) concentrations independent of the size of circulating apolipoprotein (a) isoforms
7. Lipoprotein (a): New insights into an atherogenic lipoprotein
8. Structure and metabolism of lipoprotein (a)
9. Update on lipoprotein (a)
10. A new serum type system in man - The Lp system
11. Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein (a) and that cause lipid accumulation in macrophages
12. Plasma lipoprotein distribution of apolipoprotein (a) in the fed and fasted states
13. Post-prandial Lp (a): Identification of a triglyceride-rich particle containing apo E
14. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of Lp(a)
15. Apolipoprotein(a) is present in the triglyceride-rich fraction in type IV hypertriglyceridemia
16. Isolation and characterization of two subspecies of Lp (a), one containing apo E and one free of apo E
17. Effect of storage of sera and apolipoprotein(a) phenotypes on detection of lipoprotein(a) by a new agarose gel
18. Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemia
19. Apolipoprotein C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: The ECTIM study
20. Apolipoprotein E phenotyping from serum by Western blotting
21. Lipoprotein (a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia
22. Triglyceride-rich lipoprotein interactions with Lp(a)
23. Interrelationship of triglyceride-rich lipoproteins, serum Lp(a) concentration and apolipoprotein(a) size
24. Decreased plasma levels of Lp(a) in patients with hypertriglyceridemia
25. Effect of hypertriglyceridemia on Lp(a) serum concentrations
26. Identification of apoB-containing lipoprotein families in NIDDM
27. Interactions of low density lipoprotein 2 and other apolipoproteinB-containing lipoproteins with Lp(a)
28. Lp(a) binding to other apolipoprotein B-containing lipoproteins
29. Interaction of apo(a) with apoB-containing lipoproteins
30. Lipoprotein (a) levels in diabetes mellitus: Relationship to metabolic control
31. Elevated plasma lipoprotein (a) in patients with the nephrotic syndrome
32. Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: A preliminary report